Haleon (NYSE:HLN) Stock Rating Lowered by The Goldman Sachs Group

Haleon (NYSE:HLN) was downgraded by The Goldman Sachs Group from a “buy” rating to a “neutral” rating in a research note issued to investors on Tuesday, MarketBeat reports.

Several other research analysts have also commented on the stock. HSBC assumed coverage on shares of Haleon in a research note on Wednesday, April 17th. They set a “buy” rating for the company. Berenberg Bank assumed coverage on shares of Haleon in a research note on Wednesday, June 5th. They set a “buy” rating for the company. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, Haleon has a consensus rating of “Moderate Buy”.

Haleon Stock Up 0.9 %

NYSE HLN opened at $9.61 on Tuesday. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. The company has a fifty day moving average of $8.72 and a two-hundred day moving average of $8.46. The firm has a market capitalization of $43.88 billion, a price-to-earnings ratio of 32.03, a PEG ratio of 2.69 and a beta of 0.24. Haleon has a 52 week low of $7.70 and a 52 week high of $9.73.

Haleon (NYSE:HLN) last posted its quarterly earnings data on Thursday, August 1st. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.01). The firm had revenue of $3.50 billion for the quarter, compared to analysts’ expectations of $3.55 billion. Haleon had a return on equity of 19.85% and a net margin of 9.71%. During the same period in the previous year, the firm earned $0.08 earnings per share. On average, analysts predict that Haleon will post 0.47 earnings per share for the current year.

Institutional Trading of Haleon

A number of hedge funds have recently added to or reduced their stakes in the business. Clearbridge Investments LLC lifted its stake in Haleon by 44.6% in the first quarter. Clearbridge Investments LLC now owns 38,446,978 shares of the company’s stock worth $326,415,000 after acquiring an additional 11,865,076 shares during the period. Wellington Management Group LLP lifted its stake in Haleon by 164.6% in the fourth quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock worth $111,454,000 after acquiring an additional 8,423,475 shares during the period. Douglas Lane & Associates LLC lifted its stake in Haleon by 1.6% in the second quarter. Douglas Lane & Associates LLC now owns 8,533,768 shares of the company’s stock worth $70,489,000 after acquiring an additional 131,892 shares during the period. Goldman Sachs Group Inc. lifted its stake in Haleon by 19.1% in the fourth quarter. Goldman Sachs Group Inc. now owns 4,813,997 shares of the company’s stock worth $39,619,000 after acquiring an additional 772,829 shares during the period. Finally, Martin Investment Management LLC lifted its stake in Haleon by 12,018.4% in the first quarter. Martin Investment Management LLC now owns 4,463,205 shares of the company’s stock worth $37,893,000 after acquiring an additional 4,426,375 shares during the period. 6.67% of the stock is owned by hedge funds and other institutional investors.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.